In the latest trading session,, 43.04 million Protagenic Therapeutics Inc (NASDAQ:PTIX) shares changed hands as the company’s beta touched 0. With the company’s most recent per share price at $10.04 changing hands around $7.01 or 231.35% at last look, the market valuation stands at $5.90M. PTIX’s current price is a discount, trading about -160.76% off its 52-week high of $26.18. The share price had its 52-week low at $2.35, which suggests the last value was 76.59% up since then.
Protagenic Therapeutics Inc (NASDAQ:PTIX) trade information
Instantly PTIX is in green as seen in intraday trades today. With action 228.10%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 46.36%, with the 5-day performance at 228.10% in the green. However, in the 30-day time frame, Protagenic Therapeutics Inc (NASDAQ:PTIX) is 198.93% up.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -10.56%.
PTIX Dividends
Protagenic Therapeutics Inc is expected to release its next quarterly earnings report in June.
Among Mutual Funds, the top two as of Mar 31, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 3.27 shares estimated at $33353.0 under it, the former controlled 0.56% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 0.39% of the shares, roughly 2.29 shares worth around $23306.0.
